Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 177.8 M191.55 M177.59 M196.14 M159.42 M 724.7 M Research & development ————— — Operating income 74.67 M100.13 M133.8 M-283.44 M119.9 M 70.39 M Non-Operating Income, Total -10.81 M1.25 M-21.2 M8.73 M-123.1 M -134.31 M Interest expense, net of interest capitalized 27.88 M29.97 M25.4 M23.77 M26.74 M 105.89 M Non-Operating Income, excl. Interest Expenses -26.48 M-28.87 M-23.98 M-27.15 M-25.71 M -105.71 M Unusual income/expense -12.21 M154 K-22.62 M12.1 M-124.13 M -134.5 M Pretax income 35.98 M71.42 M87.2 M-99.5 M-29.94 M 29.17 M Equity in earnings ————— — Taxes 10.1 M18.73 M31.64 M-17.81 M-15.14 M 17.42 M Non-controlling/minority interest 409 K367 K1.13 M265 K41 K 1.81 M After tax other income/expense -3.73 M1.47 M-1.04 M802 K34.67 M 35.9 M Net income before discontinued operations 25.47 M52.33 M54.42 M-276.56 M-14.84 M -184.65 M Discontinued operations ————— — Net income 25.47 M52.33 M54.42 M-276.56 M-14.84 M -184.65 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 25.47 M52.33 M54.42 M-276.56 M-14.84 M -184.65 M Basic earnings per share (Basic EPS) 0.51.061.11-5.58-0.3 -3.71 Diluted earnings per share (Diluted EPS) 0.51.061.1-5.57-0.3 -3.71 Average basic shares outstanding 50.68 M49.15 M49.21 M49.56 M48.95 M — Diluted shares outstanding 50.85 M49.32 M49.43 M49.56 M48.95 M — EBITDA 833.25 M849.49 M872.86 M8.47 M771.95 M 2.5 B EBIT 712.89 M729.99 M787.7 M-69.81 M704.8 M 2.15 B Cost of revenue 6.76 M4.3 M-370 K1.75 M1.49 M 7.17 M Other cost of goods sold 6.76 M4.3 M-370 K1.75 M1.49 M 7.17 M Depreciation & amortization (cash flow) 120.36 M119.51 M85.16 M78.28 M67.15 M 350.1 M